Ventricular dysfunction and high hypertrophy may influence surgical outcome in aortic stenosis. Our aim was to determine whether an excessive left ventricular mass index (LVMI) discriminates different risk profiles in aortic stenosis with low ventricular ejection fraction (LVEF). Three hundred and thirty-nine patients with severe aortic stenosis underwent valve replacement (Mar-1994 and Nov-2001). LVMI values over the superior quartile were considered increased. Mortality models were constructed in global and LVEFF50% groups. In-hospital mortality was higher in increased LVMI group: 9.6 vs. 1.9%, P-0.01. In LVEFF50%-increased LVMI patients this mortality was also higher: 26.3 vs. 2.4%, P-0.05. Patients without LV dysfunction and increased LVMI did not show significant difference: 4.7 vs. 1.8%, Ps0.41. Chronic renal failure (OR: 11.72, P-0.05), cardiopulmonary bypass time (OR: 1.03, P-0.01) and LVMI (gym ) (OR: 1.01, P-0.01) were 2 associated with mortality. In patients with LVEFF50%, LVMI was the strongest predictor of death. Cummulative mortality was higher with increasing LVMI and low LVEF. In conclusion, LVMI in patients with severe aortic stenosis and low LVEF might discern two different situations: an advanced cardiomyopathy with excessive hypertrophy (high LVMI-low LVEF) with poor prognosis, and an inadequate adaptive hypertrophy (low LVMI-low LVEF) in patients with afterload mismatch and more favorable outcome.
Introduction
Patients with severe aortic stenosis and impairment of ventricular function constitute a high risk group for aortic valve replacement w1-4x. They are also a challenging group because of their heterogeneous response: some patients have favourable results and others have high operative mortality and lower late survival w5x. Ventricular hypertrophy is also a negative factor w6,7x. The association of both factors may impact surgical outcome.
Our aim was to determine whether an excessive left ventricular mass index (LVMI) discriminates among different risk profiles in patients with aortic stenosis and low ejection fraction (LVEF).
Materials and methods

Study group
All patients who underwent aortic valve replacement between Mar-1994 and Nov-2001 were identified from our prospectively maintained database. From 605 patients only those with pure or predominant aortic stenosis were included (392 patients). Concomitant procedures, emergent operations and lack of preoperative echocardiographic data were exclusion criteria. Finally, 339 patients were considered.
Echocardiographic study
Preoperative Doppler Echocardiography was performed in all patients. Normal systolic function was considered if LVEF )50%. Conversely, systolic dysfunction was defined as LVEF F50%.
LVMI was calculated by Devereux9s formula w8,9x considering the diastolic measurements of left ventricular internal diameter (LVID), interventricular septal thickness (IVST) and posterior wall thickness (PWT):
Body surface area.
According to this formula, LVMI is increased if )134 gym in men and )110 gym in women. We have evaluated 2 2 higher degrees of LVMI and a new cut-off point was established arbitrarily at the first value of the superior quartile on the frequency distribution of LVMI values in both sexes.
Operative technique
Standard techniques with extracorporeal circulation were used. Myocardial protection was similar during the study: Downloaded from https://academic.oup.com/icvts/article-abstract/4/3/260/652254 by guest on 01 February 2019 moderate hemodilution and multidose intermittent cold blood cardioplegia through the aortic root or into the coronary ostia. Antegradeyretrograde delivery was also routinely used. Prosthesis size and type were used to the discretion of the surgeon (Table 1) .
Variables and definitions
The variables were based on demographics, clinical data, comorbidity and cardiac risk factors, cause of valvular lesion, echocardiographic, surgical and postoperative data.
Severe LV dysfunction was defined as LVEFF35%. Previous stroke was defined as history of a central neurologic deficit )72 h. Chronic renal insufficiency was defined as creatinine G2 mgydl. Chronic Obstructive Pulmonary Disease was defined as the need for pharmacologic therapy for chronic pulmonary compromise or as a preoperative espirometry with a moderate or severe obstruction. Urgent operation was considered when the surgical procedure was performed during the hospital stay of an acute episode. Respiratory failure was considered as the need for respiratory support for )48 h and postoperative renal failure as the increase in baseline creatinine value )2 mgydl in the absence of end-stage renal failure on dialysis. Low cardiac output when postoperative inotropic support was used )24 h. Finally, in-hospital mortality was defined as death at any time before hospital discharge.
Statistical analysis
Statistical analysis was performed using SPSS 10.0 for Windows (SPSS Inc, Chicago, IL). Continuous variables were summarized as mean"standard deviation if normally distributed, on the contrary, median and inter-quartile ranges were used. Nominal data were presented as frequencies and percentages. Continuous variables were compared by unpaired t-test. Mann-Whitney test was used to compare not normally distributed data. Associations among categorical variables were compared by Pearson9s x test, conti-2 nuity correction or two-sided Fisher exact test as appropriate.
Cummulative mortality associated to increasing LVMI values was calculated by hazard-function analysis. Comparison of hazard functions according to LVEF group was performed by Mantel-Cox and Breslow tests. Logistic regression was used to predict in-hospital mortality. Several stepwise logistic-regression models predicting in-hospital death associated to LVMI were obtained: one considering LVMI as a continuous variable, and the other considering the superior quartile as increased LVMI. A final model was performed in patients with LVEFF50%. The receiver-operating characteristic (ROC) curve was obtained and its extrapolation to sensitivity-specificity curves gave us the best discriminant LVMI value for mortality prediction (curves crossing point). Models fit was evaluated using the Hosmer and Lemeshow goodness-of-fit statistic and the area under the ROC curve was calculated. Table 2 . Patients with elevated LVMI were older and with lower LVEF. Rheumatic disease and previous atrial fibrillation were more frequent in not increased LVMI group. Other demographic characteristics, symptoms, comorbidities and cardiovascular risk factors were similar, except for a higher percentage of hypertension, hyperlipidemia and CCS angina class GIII in not increased LVMI group. Urgent operations and mean ischemic and cardiopulmonary bypass times were similar. Ninety-eight bioprostheses and 241 mechanical prostheses were implanted and bioprostheses were more frequent in increased LVMI group.
Results
Preoperative characteristics and surgical data
The mean indexed Effective Orifice Area (iEOA) was: 1.01"0.28 vs. 1.00"0.27 cm ym and the prevalence of 2 2 patient-prosthesis mismatch (iEOAF0.85 cm ym ) was sim-2 2 ilar. Preoperative echocardiographic data are presented in Table 3 .
Postoperative outcome
Univariate comparisons of postoperative morbidity are presented in Table 4 . Hospital stay was slightly longer in increased LVMI group.
In-hospital mortality
Thirteen patients died (3.8%). In-hospital mortality in LVEFF50% subgroup (ns60) was 10.0% (6 patients) in contrast to 2.5% (7 patients) in the subgroup with LVEF)50% (P-0.05). Mortality was also higher in patients with increased LVMI: 9.6% (8 patients) vs. 1.9% (5 patients) (P-0.01). Mortality according to preoperative LVEF and LVMI is summarized in Table 5 .
Univariate associations to mortality are presented in Table  6 (A). Independent predictors of mortality are presented in Table 6 (B). The first model showed that LVMI (continuous variable) was significantly associated to mortality. Increased LVMI was also identified as an independent predictor (Table 6 , model 2). We added a LVEF-LVMI interaction term (Table 6 , model 3) obtaining a high statistical significance. So, patients with increased LVMI and LVEFF50% were at high risk of mortality. LVMI was the strongest predictor of death in LVEFF50% subgroup (Table 6 , model 4). An ROC curve was obtained and the calculated LVMI cut-off point from the intersection of sensitivity-especificity curves was around 220 gym .
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Cummulative mortality associated to increasing LVMI values is presented in Fig. 1 . Patients with LVEFF50% had a higher cumulative mortality (Fig. 1b) , but this was particularly true in the superior strata of LVMI (Fig. 1d) .
Different risk profiles
Two subgroups of patients with LVEFF50% have been obtained according to the LVMI cut-off point (220 gym ).
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Comparisons are reflected in Table 7 . Despite the small sample size, several differences have been observed. Patients with LVMI )220 gym were slightly older and with 2 low body surface area. Female sex was most prevalent in not increased LVMI group. Smoking, diabetes, hypertension, hyperlipidemia, chronic atrial fibrillation and rheumatic disease were also more frequent in this group. The same occurred with associated grade 1-2 mitral regurgitation ( Table 7) . Increased LVMI group had not only a higher ventricular hypertrophy but also a more dilated left ventricle and lower LVEF. Lower transvalvular gradients were also observed with more accentuated left ventricular dysfunction ( Table 7) . A higher mortality was the consequence of this higher risk: 26.3% (5 patients) vs. 2.4% (1 patient); P-0.05. Postoperative low cardiac output syndrome was also more frequent: 3 (15.8%) vs. 2 (4.9%) (Ps0.35).
Discussion
Aortic valve replacement in patients with aortic stenosis or regurgitation and severe left ventricular dysfunction continues to be associated with a high mortality risk despite surgical and cardiological improvements w1-5x. Early referral for surgery has largely solved the problem of high mortality associated to left ventricular dysfunction in the context of aortic regurgitation w5x. On the contrary, patients with severe aortic stenosis constitute a challenging group with a more heterogeneous response. On one side, patients with critical aortic stenosis and low ejection fraction due to 'afterload mismatch' (depressed ejection performance resulting from excessively high systolic ventricular wall stress secondary to aortic stenosis) generally respond well to surgery, which immediately normalizes left ventricular afterload. Conversely, other patients with critical aortic stenosis and advanced left ventricular systolic dysfunction, Downloaded from https://academic.oup.com/icvts/article-abstract/4/3/260/652254 by guest on 01 February 2019 Data are presented as percent of patients who died (n deathsyn at risk). who usually present with low gradients and cardiac output, constitute a high operative risk subgroup w5x.
Other factors w10-12x that increase morbimortality are: associated coronary artery disease, renal insufficiency, advanced age, prior aortic valve replacement, aortic regurgitation, atrial fibrillation, patient-prosthesis mismatch, low body surface area, CPB time, type of prosthesis, etc. Elevated LVMI has also been considered w6,7,13x. Unfortunately, many of previous studies have included patients with aortic insufficiency or undergoing concomitant proce- dures, which complicates comparisons. We were especially restrictive with the selection criteria and we have only considered patients with isolated aortic stenosis.
Increased LVMI could be responsible of higher mortality by means of contractile impairment, diastolic dysfunction, abnormalities of coronary flow reserve or cardiac arrhythmias w6,7x. This factor was the strongest predictor of death in our patients with LVEFF50%. In the global group, preoperative LVEF was associated with mortality in univariate analysis and it was also an independent predictor when increased LVMI-LVEFF50% interaction was tested. But some patients with low LVEF have not increased LVMI and they had a better survival (Table 5 ). So, LVMI in patients with aortic stenosis and low LVEF might discern two groups of patients with different outcomes.
In valvular aortic stenosis, concentric hypertrophy maintains left ventricular chamber size and ejection fraction within normal limits, but in late stages, function can deteriorate as preload reserve is lost. Even when the ejection fraction is markedly reduced, it can improve to normal after surgery, suggesting that afterload mismatch rather than irreversibly depressed myocardial contractility was responsible for left ventricular failure. This mismatch occurs when an inadequate adaptive hypertrophy is present w14x. These patients have a low LVEF and a 'not increased LVMI' because adaptative hypertrophy has been insufficient. But in other patients without afterload mismatch, the operative risk is high and the improvement of left ventricular function may not be complete. An irreversibly depressed contractility may be the result of excessive hypertrophy and fibrosis w2x. These patients have a low LVEF and a severely increased LVMI. Survival is still improved with the possible exception of patients with severe ventricular dysfunction caused by coronary disease w2,4x. Therefore, patients with severe aortic stenosis should not be denied operation because of impaired cardiac function, but it would be important to unmasked this irreversibly depressed myocardial contractility. The evaluation of the hypertrophic response might be a useful tool. We must consider a real 'dysfunction' in this adaptive mechanism to afterload increase. It should be secondary to an inadequate hypertrophy (insufficient or excessive) with respect to the increased afterload. The factors associated to this inadequate adaptation are not completely known w15x. Hypertension, diabetes and pharmacologic treatments may have a significant role. Other factors include sex, race, genetic and neurohumoral such as levels of angiotensin and other trophic hormones that might modulate hypertrophy. Several factors have been associated more frequently to our patients with low LVEF and not increased LVMI: female sex, hypertension, diabetes, rheumatic disease or low grade mitral regurgitation. Palta et al. w15x concluded that mitral regurgitation in severe aortic stenosis is associated with larger ventricles and lesser wall thickness, and this may result from failure of adequate hypertrophy. Grade 1-2 mitral regurgitation was more frequent in not increased LVMI group in our patients with LVEFF50%. Higher grades of regurgitation were not found because concomitant surgical procedures were excluded. In summary, in these, challenging patients with severe aortic stenosis and low LVEF, LVMI might discern two different situations: an advanced cardiomyopathy with excessive hypertrophy (high LVMI-low LVEF) with worse outcome, and an insufficient adaptive hypertrophy (low LVMI-low LVEF) in patients with afterload mismatch and more favourable results. Future studies are needed to find the possible factors implicated in this different hypertrophic response to afterload increase.
Limitations of the study
A retrospective, non-randomized analysis in a single center is subjected to the effects of selection bias. Another limitation is the reduced number of patients with LVEFF50%, because severe aortic stenosis and ventricular dysfunction is not a frequent association (a common limitation in previous studies). The comparison in this subgroup is limited by the small sample size. Thus, further research in larger series is needed to elucidate mechanisms of ventricular remodelling in patients with aortic stenosis and ventricular dysfunction.
